{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:54:29Z","timestamp":1740174869674,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The gold standard treatment for locally advanced colon cancer is curative surgery followed by adjuvant chemotherapy, although this approach is associated with serious concerns, such as high recurrence rates and occasionally unnecessary oversurgery. Neoadjuvant chemotherapy may be a promising strategy for overcoming these issues. This study reports a case of a recurrence-free patient who underwent curative resection without significant organ dysfunction after preoperative chemotherapy for locally advanced sigmoid colon cancer. The tumor coexisted with a large intra-abdominal abscess, and the patient was quite frail at the first visit. We performed percutaneous drainage followed by preoperative panitumumab monotherapy, which yielded favorable outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 78-year-old frail woman was emergently transferred to our hospital with fever and abdominal pain. The diagnosis was locally advanced sigmoid colon cancer stage IIIC (T4bN2aM0) with a large intra-abdominal abscess. Immediate curative surgery was inappropriate, considering both tumor progression and the patient\u2019s frailty. We performed percutaneous drainage and colostomy construction, which was followed by seven cycles of preoperative panitumumab monotherapy without significant adverse events. After these treatments, inflammation was well controlled, and the tumor shrank remarkably. Furthermore, the patient recovered well from frailty; therefore, curative sigmoidectomy combined with resection of the left ovary and stoma closure was possible without any postoperative complications. The final pathological finding was T3N0M0, stage IIA disease. The patient was recurrence-free and had no significant organ dysfunction 21\u00a0months after the curative surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The management of intra-abdominal abscesses and tailor-made preoperative chemotherapy based on the patient\u2019s frailty may have been the key factors responsible for the favorable course of this patient. Although further research is needed on the appropriateness of percutaneous drainage for malignancies related to intra-abdominal abscesses and preoperative panitumumab use for locally advanced colon cancer, the study findings can serve as reference for managing similar cases in an aging society.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-023-01800-x","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T03:02:47Z","timestamp":1705546967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Curative resection after percutaneous drainage followed by preoperative panitumumab monotherapy for locally advanced sigmoid colon cancer with intra-abdominal abscess: a case report"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7908-374X","authenticated-orcid":false,"given":"Yusuke","family":"Asada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Takenoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Oto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Osumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Kameyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"1800_CR1","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S1470-2045(14)70227-X","volume":"15","author":"J Taieb","year":"2014","unstructured":"Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL, et al. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial. Lancet Oncol. 2014;15:862\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(14)70227-X.","journal-title":"Lancet Oncol"},{"key":"1800_CR2","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1200\/JCO.2017.76.0355","volume":"36","author":"T Andr\u00e9","year":"2018","unstructured":"Andr\u00e9 T, Vernerey D, Mineur L, Bennouna J, Desrame J, Faroux R, et al. Three versus 6 months of oxaliplatin-based adjuvant chemotherapy for patients with stage III colon cancer: disease-free survival results from a randomized, open-label, international duration evaluation of adjuvant (IDEA) France. Phase III trial J Clin Oncol. 2018;36:1469\u201377. https:\/\/doi.org\/10.1200\/JCO.2017.76.0355.","journal-title":"Phase III trial J Clin Oncol"},{"key":"1800_CR3","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s00268-017-4193-2","volume":"42","author":"A Tsuchiya","year":"2018","unstructured":"Tsuchiya A, Yasunaga H, Tsutsumi Y, Matsui H, Fushimi K. Mortality and morbidity after Hartmann\u2019s procedure versus primary anastomosis without a diverting stoma for colorectal perforation: a nationwide observational study. World J Surg. 2018;42:866\u201375. https:\/\/doi.org\/10.1007\/s00268-017-4193-2.","journal-title":"World J Surg"},{"key":"1800_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.amjsurg.2019.02.025","volume":"218","author":"D Moro-Valdezate","year":"2019","unstructured":"Moro-Valdezate D, Royo-Aznar A, Mart\u00edn-Ar\u00e9valo J, Pla-Mart\u00ed V, Garc\u00eda-Botello S, Le\u00f3n-Espinoza C, et al. Outcomes of Hartmann\u2019s procedure and subsequent intestinal restoration. Which patients are most likely to undergo reversal? Am J Surg. 2019;218:918\u201327. https:\/\/doi.org\/10.1016\/j.amjsurg.2019.02.025.","journal-title":"Am J Surg"},{"key":"1800_CR5","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s10350-006-0613-3","volume":"49","author":"D Brandt","year":"2006","unstructured":"Brandt D, Gervaz P, Durmishi Y, Platon A, Morel P, Poletti PA. Percutaneous CT scan-guided drainage vs. antibiotherapy alone for Hinchey II diverticulitis: a case-control study. Dis Colon Rectum. 2006;49:1533\u20138. https:\/\/doi.org\/10.1007\/s10350-006-0613-3.","journal-title":"Dis Colon Rectum"},{"key":"1800_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10151-014-1250-9","volume":"19","author":"F Elagili","year":"2015","unstructured":"Elagili F, Stocchi L, Ozuner G, Kiran RP. Antibiotics alone instead of percutaneous drainage as initial treatment of large diverticular abscess. Tech Coloproctol. 2015;19:97\u2013103. https:\/\/doi.org\/10.1007\/s10151-014-1250-9.","journal-title":"Tech Coloproctol"},{"key":"1800_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/s0016-5107(92)70385-x","volume":"38","author":"P Vilmann","year":"1992","unstructured":"Vilmann P, Jacobsen GK, Henriksen FW, Hancke S. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc. 1992;38:172\u20133. https:\/\/doi.org\/10.1016\/s0016-5107(92)70385-x.","journal-title":"Gastrointest Endosc"},{"key":"1800_CR8","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/00000658-198906000-00008","volume":"209","author":"WC Chapman","year":"1989","unstructured":"Chapman WC, Sharp KW, Weaver F, Sawyers JL. Tumor seeding from percutaneous biliary catheters. Ann Surg. 1989;209:708\u201313. https:\/\/doi.org\/10.1097\/00000658-198906000-00008.","journal-title":"Ann Surg"},{"key":"1800_CR9","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S1470-2045(12)70348-0","volume":"13","author":"Foxtrot Collaborative Group","year":"2012","unstructured":"Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: The pilot phase of a randomised controlled trial. Lancet Oncol. 2012;13:1152\u201360. https:\/\/doi.org\/10.1016\/S1470-2045(12)70348-0.","journal-title":"Lancet Oncol"},{"key":"1800_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11605-017-3566-z","volume":"22","author":"A Dehal","year":"2018","unstructured":"Dehal A, Graff-Baker AN, Vuong B, Fischer T, Klempner SJ, Chang SC, et al. Neoadjuvant chemotherapy improves survival in patients with clinical T4b colon cancer. J Gastrointest Surg. 2018;22:242\u20139. https:\/\/doi.org\/10.1007\/s11605-017-3566-z.","journal-title":"J Gastrointest Surg"},{"key":"1800_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/SLA.0000000000003454","volume":"271","author":"M Karoui","year":"2020","unstructured":"Karoui M, Rullier A, Piessen G, Legoux JL, Barbier E, De Chaisemartin C, et al. Perioperative FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a phase II multicenter randomized controlled trial (PRODIGE 22). Ann Surg. 2020;271:637\u201345. https:\/\/doi.org\/10.1097\/SLA.0000000000003454.","journal-title":"Ann Surg"},{"key":"1800_CR12","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1200\/JCO.2013.53.2473","volume":"32","author":"LS Schwartzberg","year":"2014","unstructured":"Schwartzberg LS, Rivera F, Karthaus M, Fasola G, Canon JL, Hecht JR, et al. PEAK: A randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer. J Clin Oncol. 2014;32:2240\u20137. https:\/\/doi.org\/10.1200\/JCO.2013.53.2473.","journal-title":"J Clin Oncol"},{"key":"1800_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ONCO.13523","volume":"26","author":"T Terazawa","year":"2021","unstructured":"Terazawa T, Kato T, Goto M, Ohta K, Noura S, Satake H, et al. Phase II study of panitumumab monotherapy in chemotherapy-na\u00efve frail or elderly patients with unresectable RAS wild-type colorectal cancer: OGSG 1602. Oncologist. 2021;26:17-e47. https:\/\/doi.org\/10.1002\/ONCO.13523.","journal-title":"Oncologist"},{"key":"1800_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijscr.2017.01.027","volume":"31","author":"K Tomizawa","year":"2017","unstructured":"Tomizawa K, Miura Y, Fukui Y, Hanaoka Y, Toda S, Moriyama J, et al. Curative resection for locally advanced sigmoid colon cancer using neoadjuvant chemotherapy with FOLFOX plus panitumumab: a case report. Int J Surg Case Rep. 2017;31:128\u201331. https:\/\/doi.org\/10.1016\/j.ijscr.2017.01.027.","journal-title":"Int J Surg Case Rep"},{"key":"1800_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00384-016-2694-3","volume":"32","author":"H Asano","year":"2017","unstructured":"Asano H, Kojima K, Ogino N, Fukano H, Ohara Y, Shinozuka N. Postoperative recurrence and risk factors of colorectal cancer perforation. Int J Colorectal Dis. 2017;32:419\u201324. https:\/\/doi.org\/10.1007\/s00384-016-2694-3.","journal-title":"Int J Colorectal Dis"},{"key":"1800_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/000313480106700312","volume":"67","author":"S Khan","year":"2001","unstructured":"Khan S, Pawlak SE, Eggenberger JC, Lee CS, Szilagy EJ, Margolin DA. Acute colonic perforation associated with colorectal cancer. Am Surg. 2001;67:261\u20134. https:\/\/doi.org\/10.1177\/000313480106700312.","journal-title":"Am Surg"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-023-01800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-023-01800-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-023-01800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T03:04:56Z","timestamp":1705547096000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-023-01800-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1800"],"URL":"https:\/\/doi.org\/10.1186\/s40792-023-01800-x","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"26 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and the accompanying images. A copy of the written consent form is available for review by the editor-in-chief of this journal upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}